218 related articles for article (PubMed ID: 12718717)
1. Chemical genomics as an emerging paradigm for postgenomic drug discovery.
Salemme FR
Pharmacogenomics; 2003 May; 4(3):257-67. PubMed ID: 12718717
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial informatics in the post-genomics ERA.
Agrafiotis DK; Lobanov VS; Salemme FR
Nat Rev Drug Discov; 2002 May; 1(5):337-46. PubMed ID: 12120409
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery and development using chemical genomics.
Sehgal A
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):526-31. PubMed ID: 12197310
[TBL] [Abstract][Full Text] [Related]
4. High-throughput virtual screening for drug discovery in parallel.
Toledo-Sherman LM; Chen D
Curr Opin Drug Discov Devel; 2002 May; 5(3):414-21. PubMed ID: 12058617
[TBL] [Abstract][Full Text] [Related]
5. Computational chemogenomics approaches to systematic knowledge-based drug discovery.
Mestres J
Curr Opin Drug Discov Devel; 2004 May; 7(3):304-13. PubMed ID: 15216933
[TBL] [Abstract][Full Text] [Related]
6. Molecular recognition: the fragment approach in lead generation.
Fattori D
Drug Discov Today; 2004 Mar; 9(5):229-38. PubMed ID: 14980541
[TBL] [Abstract][Full Text] [Related]
7. Design of diversity and focused combinatorial libraries in drug discovery.
Young SS; Ge N
Curr Opin Drug Discov Devel; 2004 May; 7(3):318-24. PubMed ID: 15216935
[TBL] [Abstract][Full Text] [Related]
8. Chemical genomics versus orthodox drug development.
Szymkowski DE
Drug Discov Today; 2003 Feb; 8(4):157-9. PubMed ID: 12581708
[No Abstract] [Full Text] [Related]
9. Macromolecular therapeutics: emerging strategies for drug discovery in the postgenome era.
Juliano RL; Astriab-Fisher A; Falke D
Mol Interv; 2001 Apr; 1(1):40-53. PubMed ID: 14993337
[TBL] [Abstract][Full Text] [Related]
10. [Drug discovery based on genomic information].
Nohmi T
Rinsho Byori; 2002 Jul; 50(7):694-7. PubMed ID: 12187707
[TBL] [Abstract][Full Text] [Related]
11. Exploiting genomics, genetics and chemistry to combat antibiotic resistance.
Hughes D
Nat Rev Genet; 2003 Jun; 4(6):432-41. PubMed ID: 12776213
[TBL] [Abstract][Full Text] [Related]
12. The chemical hunt for the identification of drugable targets.
Meisner NC; Hintersteiner M; Uhl V; Weidemann T; Schmied M; Gstach H; Auer M
Curr Opin Chem Biol; 2004 Aug; 8(4):424-31. PubMed ID: 15338571
[TBL] [Abstract][Full Text] [Related]
13. Genomics and proteomics tools for compound mode-of-action studies in drug discovery.
Kley N; Ivanov I; Meier-Ewert S
Pharmacogenomics; 2004 Jun; 5(4):395-404. PubMed ID: 15165175
[TBL] [Abstract][Full Text] [Related]
14. Current directions in the evolution of compound libraries.
Webb TR
Curr Opin Drug Discov Devel; 2005 May; 8(3):303-8. PubMed ID: 15892244
[TBL] [Abstract][Full Text] [Related]
15. Novel antibacterials: a genomics approach to drug discovery.
Chan PF; Macarron R; Payne DJ; Zalacain M; Holmes DJ
Curr Drug Targets Infect Disord; 2002 Dec; 2(4):291-308. PubMed ID: 12570737
[TBL] [Abstract][Full Text] [Related]
16. The emergence of chemical genomics in drug discovery.
Zanders ED; Gordon RD; Gershater CJ
IDrugs; 2005 Nov; 8(11):919-23. PubMed ID: 16254786
[TBL] [Abstract][Full Text] [Related]
17. Continuous flow reactors for drug discovery.
Watts P; Haswell SJ
Drug Discov Today; 2003 Jul; 8(13):586-93. PubMed ID: 12850334
[TBL] [Abstract][Full Text] [Related]
18. The use of chemical design tools to transform proteomics data into drug candidates.
Dean PM; Zanders ED
Biotechniques; 2002 Mar; Suppl():28-33. PubMed ID: 11906004
[TBL] [Abstract][Full Text] [Related]
19. Forecasting roles of combinatorial chemistry in the age of genomically derived drug discovery targets.
Thorpe DS
Comb Chem High Throughput Screen; 2000 Oct; 3(5):421-36. PubMed ID: 11032958
[TBL] [Abstract][Full Text] [Related]
20. The impact of genomics on anti-infectives drug discovery and development.
Parkinson T
Trends Microbiol; 2002; 10(10 Suppl):S22-6. PubMed ID: 12377564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
